Oxytocin Suppresses Inflammatory Responses Induced by Lipopolysaccharide through Inhibition of the eIF-2-ATF4 Pathway in Mouse Microglia.
Level 5 - mechanism / opinion, no new human data
In vitro bench research using mouse microglia
PubMed 31159306 · doi:10.3390/cells8060527
What was done
Investigators treated mouse microglia with lipopolysaccharide (LPS) to model neuroinflammation and endoplasmic reticulum (ER) stress. They evaluated the involvement of the eIF-2α-ATF4 pathway in cytokine production and tested whether oxytocin administration suppresses LPS-mediated inflammatory responses.
What was found
LPS stimulation activated the ER stress-related eIF-2α-ATF4 pathway, which promoted TNF-α, IL-6, and inflammasome-mediated IL-1β production in mouse microglia. Oxytocin treatment suppressed the production of these proinflammatory cytokines by inhibiting the activation of the eIF-2α-ATF4 pathway. The abstract reports no numerical values, concentrations, or statistical metrics.
Why it matters
This study identifies the eIF-2α-ATF4 pathway as a mechanistic mediator of microglial inflammation and demonstrates that oxytocin can suppress this pathway in vitro, suggesting a potential target for neuroinflammatory modulation.
Limits
Findings are restricted to in vitro mouse microglial cell cultures and cannot be directly translated to human neuroinflammation. The abstract provides no quantitative data, sample sizes, experimental replicates, or in vivo functional validations.
Cited by
- supports Research indicates that oxytocin downregulates pro-inflammatory cytokines in the brain and acts on brain immune cells to lower inflammatory responses.